Regulatory Affairs

Global updates on medical device regulation and quality.

441 articles
Home / Regulatory Affairs
441 articles in Regulatory Affairs
Latest News

FDA Issues Serious Correction Notification for BD Alaris Pump Modules Due to Safety Risks

The United States Food and Drug Administration (FDA) has released an updated correction notification for BD Alaris pump modules. These…

Europe

Important Patient-Level Recall: Algifor Junior Suspension 200 ml and Algifor Dolo Junior Suspension 200 ml

Swissmedic issues a patient-centric recall for specific batches of Algifor Junior Suspension 200 ml and Algifor Dolo Junior Suspension 200…

Europe

Swissmedic Announces New Therapeutic Indication for Tepkinly®

Swissmedic has announced an update to the therapeutic indications for Tepkinly®. This regulatory approval marks an extension of the product’s…

Europe

Swissmedic Approves Enhertu® for Extended Therapeutic Indications

Swissmedic has granted authorization for the extension of therapeutic indications for Enhertu® as of November 28, 2025. This update marks…

Europe

Temporary Authorization Alert: Ringerfundin B. Braun Infusion Solution Distribution Update

Swissmedic, the Swiss Agency for Therapeutic Products, has granted a temporary approval for the distribution of Ringerfundin B. Braun Infusion…

Europe

Swissmedic Spotlights Personnel Roles: Essential Update for Teams

On November 28, 2025, Swissmedic released details regarding changes in personnel requirements within its Abteilung Personal und Organisation department. This…

Europe

Swissmedic Announces HR Business Partner Opening: A Strategic Role in Regulatory Support

Swissmedic, the Swiss Agency for Therapeutic Products, has announced an exciting job opportunity for an HR Business Partner (60–80%). This…

Europe

Temporary Authorization for Ringerlactat B. Braun Infusion Solution in German Packaging

Swissmedic announces a temporary distribution authorization for Ringerlactat B. Braun Infusion Solution packaged in German labeling. As of November 27,…

Europe

Swissmedic Opens Access to Swissdamed UDI Devices Playground

Swissmedic has announced the release of the Swissdamed UDI Devices Playground, an online tool designed to assist medical device stakeholders…

Europe

Urgent Swissmedic Recall: Specific Batch of Azelastin-Fluticason-Mepha Nasal Spray Withdrawn

On November 27, 2025, Swissmedic announced an immediate recall of batch number 100062289 of Azelastin-Fluticason-Mepha Nasal Spray, Suspension. This recall…

Latest News

Critical Recall Alert: Baxter Removes Life2000 Ventilator System Over Cybersecurity Risks

The FDA has announced a Class I recall for Baxter’s Life2000 Ventilation System, citing serious potential risks tied to cybersecurity…

Latest News

FDA Issues Urgent Recall of Mega Ballast Medical Devices Due to Serious Health Risks

The FDA has flagged a critical recall concerning Balt USA’s Mega Ballast Distal Access Platform devices, identified as carrying a…

Loading more articles…
Scroll to Top